Startups

CPTx: Biotech Company Raises $29 Million To Develop Antiviral And Biodefense Solutions

By Amit Chowdhry ● Sep 27, 2024

CPTx, an innovative biotech startup committed to pioneering next-generation preventative and therapeutic solutions, announced it has raised $29 million from a diverse group of public and private investors. This funding round was led by Blueyard Capital and SPRIND, with participation from Marius Nacht Group, Andrej Henkler - Leblon Capital, Bayern Kapital, and several industry veterans, including Stefan Oschmann, former CEO of Merck KGaA.

HyperLight: Thin Film Lithium Niobate Provider Secures $37 Million (Series B)

By Amit Chowdhry ● Sep 27, 2024

HyperLight, a leading provider of thin film lithium niobate (TFLN) photonic integrated circuits (PICs), announced a $37 million Series B investment led by Summit Partners. This funding round includes participation from existing investors Xora Innovation, a deep tech venture fund backed by Temasek, and Foothill Ventures. Peter Chung, Managing Director and CEO of Summit Partners will join HyperLight’s Board of Directors.

VerImmune: $4.5 Million (Pre-Series A) Secured To Develop Virus-Inspired Particle Platform

By Amit Chowdhry ● Sep 27, 2024

VerImmune, a venture-backed biotechnology company developing a Virus-inspired Particle (ViP) platform technology, announced the first closing of $4.5 million in its Pre-Series A funding round. The funding was led by Beiley Biofund, an early-stage venture capital firm focused on cutting-edge technologies that address high unmet medical needs. New investors, including Dr. John Ballantyne, PhD, co-founder and former CSO at Aldevron, participated in the round, alongside returning investors Proxima Ventures, Mana Ventures, Gaingels, and others.

Harmonic: Mathematical Superintelligence Company Raises $75 Million (Series A) At $325 Million Valuation

By Amit Chowdhry ● Sep 27, 2024

Harmonic, an artificial intelligence platform leading the development of Mathematical Superintelligence (MSI), announced a $75 million Series A funding round at a $325 million post-money valuation led by Sequoia Capital, with significant participation by Index Ventures and additional backing from Jasper Lau’s Era Funds, GreatPoint Ventures, DST Global partners, Nikesh Arora, and Jared Leto.

Scribenote Raises $8.2 Million (Seed) To Help Veterinarians Streamline Documentation Processes

By Amit Chowdhry ● Sep 27, 2024

Scribenote, an AI-based medical scribe for veterinarians, announced it raised $8.2 million in seed funding to tackle this problem head-on. And the company's funding was led by Andreessen Horowitz (a16z), with additional participation from Inovia Capital, the Velocity Fund, and a line-up of angel investors.

GC Therapeutics: $65 Million (Series A) Raised To Unlock The Next Generation Of Cell Therapy-Based Medicines

By Amit Chowdhry ● Sep 27, 2024

GC Therapeutics (GCTx) announced its launch to scale and unlock the next generation of cell therapy. And GCTx also completed a $65 million Series A financing led by Cormorant Asset Management with participation from Mubadala Capital, Andreessen Horowitz (a16z) Bio + Health, Medical Excellence Capital, Cercano Management, and Pear VC, bringing the total capital raised by GCTx to $75 million.

Sparrow BioAcoustics: $13 Million (Seed) Raised To Help People At Risk With Cardiac And Respiratory Disease Live Longer

By Amit Chowdhry ● Sep 27, 2024

Sparrow BioAcoustics, a pioneer in the field of bioacoustic AI technology, announced that it has closed its seed financing round. The $13 million funding was led by Killick Capital, Klister Credit, and Pelorus Ventures. The closing of the round represents a major step forward for the small Canadian medical AI startup.

Gnosis Freight: Strategic Growth Investment Raised From Vista Equity Partners

By Amit Chowdhry ● Sep 27, 2024

Gnosis Freight—a leading provider of supply chain visibility and execution software designed to manage the full lifecycle of the shipping container—announced a strategic growth investment from Vista Equity Partners, a global investment firm focused exclusively on enterprise software, data, and technology-enabled businesses. The investment supports Gnosis’ mission to help logistics companies work together better across the entire ecosystem.

Vicebio: $100 Million (Series B) Raised To Develop Novel Vaccines Against Respiratory Viral Infections

By Amit Chowdhry ● Sep 27, 2024

Vicebio, a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, announced a $100 million Series B financing led by TCGX. Goldman Sachs Alternatives, Avoro Ventures, and venBio invested, and UniQuest and founding investor Medicxi participated.

SeatBoost: Investment Raised From International Airlines Group

By Amit Chowdhry ● Sep 27, 2024

SeatBoost, a company transforming the air travel experience through dynamic seat upgrade solutions, announced an investment from the International Airlines Group (IAG). This funding round marks an important milestone in SeatBoost's mission to bring joy to travelers' experiences while generating incremental non-dilutive revenue for partner airlines.